EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Evaluation of the Sedative Activity of Naringenin: In Vivo Study with Pharmacokinetics and Molecular Docking Insights

Dipu Bishwas, Md Shimul Bhuia iD, Salehin Sheikh iD, Mohammed Alfaifi, Abdul Malik, Nikhat J Siddiqui, Divya Jain, Mehedi Hasan Bappi, Muhammad Torequl Islam

ChemistryOpen · 2025

DOI: 10.1002/open.202500114 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ChemistryOpen, 2025. Verfasst von Dipu Bishwas und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Pabna University of Science and Technology, Pabna, 6600, Bangladesh. Hauptthemen laut MEDLINE: Molecular Docking Simulation, Flavanones, Hypnotics and Sedatives. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deanship of Research and Graduate Studies at King Khalid University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This research is designed to investigate the sedative effects of naringenin (NAR) and diazepam against thiopental sodium‐induced sleeping mice. NAR (5 and 10 mg kg), diazepam (DZP) (2 mg kg), flumazenil (FLN) (0.1 mg kg), and their combinations are administered intraperitoneally to mice. After 30 min, sleep is induced with intraperitoneal thiopental sodium (20 mg kg), and sleep latency and duration are measured. In silico analysis investigates the role of GABA receptors. NAR significantly reduces sleep latency and prolongs sleep duration in a dose‐dependent manner, with the combination of NAR‐10 and DZP‐2 showing a synergistic effect. The combination of the antagonist (FLN) (NAR‐10 and FLN‐0.1) indicates that latency increases and sleep duration decreases compared to NAR‐10 alone. Furthermore, in silico docking studies corroborates these results, demonstrating a significant binding affinity of NAR (−8.3 kcal mol), which is comparable to the standard ligand DZP (−8.7 kcal mol) and FLN (−7.0 kcal mol) for the GABA A (6X3X) receptor, indicating a GABAergic mechanism. Pharmacokinetics and toxicity evaluations confirm NAR's potential as a safe therapeutic agent, with a high LD50 (2000 mg kg) and minimal toxicity. These findings highlight NAR's potential as a GABAergic sedative agent, requiring further research before being used clinically to treat sleep disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Molecular Docking SimulationFlavanonesHypnotics and SedativesAnimalsMiceDiazepamMaleSleepReceptors, GABA-AFlumazenil

Stichwörter der Autor:innen

GABAergic pathwaysin silico studiesinsomnianaringeninpharmacokinetics

Substanzen

naringeninFlavanonesHypnotics and SedativesDiazepamReceptors, GABA-AFlumazenil

Autor:innen und Institutionen

  • Department of Pharmacy, Pabna University of Science and Technology, Pabna, 6600, Bangladesh.
  • Bioinformatics and Drug Innovation Laboratory, Bioluster Research Center Ltd., Gopalganj, 8100, Dhaka, Bangladesh.
  • Department of Pharmacy, Gopalganj Science and Technology University, Gopalganj, 8100, Bangladesh.
  • Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Khalid University, Abha, 61421, Saudi Arabia.
  • Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh, 11451, Saudi Arabia.
  • Department of Internal Surgical Nursing, College of Nursing, King Saud University, Riyadh, 11451, Saudi Arabia.

ORCID-Profile: Md Shimul Bhuia, Salehin Sheikh

Förderung

  • Deanship of Research and Graduate Studies at King Khalid University

Zitieren

APA

Bishwas, D., Bhuia, M. S., Sheikh, S., Alfaifi, M., Malik, A., Siddiqui, N. J., Jain, D., Bappi, M. H., & Islam, M. T. (2025). Evaluation of the Sedative Activity of Naringenin: In Vivo Study with Pharmacokinetics and Molecular Docking Insights. ChemistryOpen. https://doi.org/10.1002/open.202500114

Vancouver

Bishwas D, Bhuia MS, Sheikh S, Alfaifi M, Malik A, Siddiqui NJ, et al. Evaluation of the Sedative Activity of Naringenin: In Vivo Study with Pharmacokinetics and Molecular Docking Insights. ChemistryOpen. 2025. doi:10.1002/open.202500114

BibTeX
@article{Bishwas2025,
  author = {Bishwas, Dipu and Bhuia, Md Shimul and Sheikh, Salehin and Alfaifi, Mohammed and Malik, Abdul and Siddiqui, Nikhat J and Jain, Divya and Bappi, Mehedi Hasan and Islam, Muhammad Torequl},
  title = {Evaluation of the Sedative Activity of Naringenin: In Vivo Study with Pharmacokinetics and Molecular Docking Insights},
  journal = {ChemistryOpen},
  year = {2025},
  doi = {10.1002/open.202500114}
}
Kostenlos starten →